Project Farma teams with Valkit.ai on AI validation tools

By AI, Created 12:31 PM UTC, May 27, 2026, /AGP/ – Project Farma has become a Gold Tier Certified Partner with Valkit.ai to bring AI-powered digital validation to regulated life sciences work. The collaboration is aimed at improving traceability, cutting validation delays and helping manufacturers move therapies through readiness faster without compromising compliance.

Why it matters: - Life sciences manufacturers face heavy validation burdens that can slow manufacturing readiness and delay therapy launches. - The partnership is aimed at making validation faster, more traceable and less resource-intensive while keeping cGMP compliance intact. - Faster validation can help patients get life-changing therapies to market sooner.

What happened: - Project Farma announced Gold Tier Certified Partner status with Valkit.ai on May 28, 2026. - The deal pairs Project Farma’s validation and manufacturing consulting work with Valkit.ai’s AI-powered digital validation platform. - The companies said the collaboration is designed to modernize validation for life sciences organizations operating in regulated environments.

The details: - Valkit.ai’s platform is built for life sciences validation and compliance workflows. - The platform is designed to streamline GxP activities such as CQV, CSV and CSA. - Features include smart automation, package cloning, master data management and an AI-augmented RAG framework for generating and adapting validation content. - Valkit.ai also offers automated requirement-risk-test mapping, version control, e-signatures and live dashboards. - The platform is cloud-native and mobile-ready. - Valkit.ai says the system can integrate with Jira, Azure DevOps and Vaisala viewLinc. - Project Farma said the partnership will help clients strengthen data integrity, improve traceability and support faster project execution. - Greg Gara, Project Farma’s chief technical officer, said validation has historically been one of the most resource-intensive parts of manufacturing readiness. - Gara said digital tools can improve visibility, execution and decision-making while helping teams move faster without compromising quality or compliance. - Hugh Devine, CEO of Valkit.ai, said Project Farma brings deep experience across complex manufacturing and validation programs in life sciences. - Devine said the collaboration balances innovation, operational execution and regulatory expectations.

Between the lines: - The announcement shows Project Farma expanding technology partnerships as AI and machine learning become more embedded in life sciences operations. - The pitch is not just automation. The companies are framing AI as a way to preserve compliance while reducing cycle time and manual work. - Project Farma is leaning on a digital validation partner to extend its consulting model into a more software-enabled service offering.

What’s next: - Project Farma directed interested clients to Tom Struble, vice president of validation services, at tomstruble@projectfarma.com. - The companies are positioning the partnership around broader adoption of modern validation workflows for life sciences manufacturers. - Project Farma will likely use the partnership to support clients looking to update validation programs in regulated settings.

The bottom line: - Project Farma is betting that AI-assisted validation can speed manufacturing readiness without lowering the bar on quality, traceability or compliance. - For life sciences companies, that could mean fewer delays and a clearer path from development to commercialization.